NeuClone Competitors and Similar CompaniesClear all
NeuClone's competitors and similar companies include Assertio and Anticancer Bioscience.
 NeuClone NeuClone is a clinical-stage biopharmaceutical company that develops and commercializes biosimilar products. |  Assertio Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. |  Anticancer Bioscience Anticancer Bioscience is a precision oncology company that applies synthetic lethal approaches to develop targeted cancer therapies. | |
Founding Date | Founding Date 2007 | Founding Date 1995 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Eveleigh, AU HQ | Locations Lake Forest, US HQ | Locations Chengdu Shi, CN HQ Hyderabad, IN St Andrews, GB San Francisco, US |
Employees | Employees 9 | Employees 3058% increase | Employees 15 |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 42.5m | Total funding raised $ 21m |
For sources of this data, please see the company profile
View Company Profiles
Assertio
HQ
Lake Forest, US
Employees
30
Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.
View companyAnticancer Bioscience
HQ
Chengdu Shi, CN
Employees
15
Anticancer Bioscience is a precision oncology company that applies synthetic lethal approaches to develop targeted cancer therapies.
View company